Inhibition of cell-mediated immune reactions by an aqueous extract of normal human skin.
An aqueous extract of normal human skin has been shown to contain an inhibitor of certain cell mediated immune reactions. In this report, the effect of the inhibitor on cell membrane markers and antibody dependent cellular cytotoxicity was determined. Significant diminution of E rosette formation was demonstrated using as little as 0.6 microgram of the skin fraction (p less than .02). Fc receptors for both IgG and IgM were reduced by 46-96% of controls in the presence of the skin inhibitor. On the other hand, no effect on the detection of the complement receptor or surface immunoglobulin was observed, indicating some specificity of binding. In addition, the antibody dependent cell-mediated cytotoxic reaction was inhibited on the skin extract. It was shown that the inhibitor interacted with the lymphocytes, not the antibody or target cells. No effect was detectable when the skin fraction was added after the interactions of effector cells, antibody, and target cells had occurred. This was in contrast to PHA-induced cytotoxicity which could be inhibited following the preincubation of the lymphocytes with the mitogen. Thus there appears to be 2 mechanisms by which the skin fraction interferes with cellular responses: inhibition of antibody binding to Fc receptors, and interference with a step in cellular activation following mitogen stimulation. Analysis of the extract showed the inhibitor was inactivated by trypsin, and did not contain sialic acid, 5'-nucleotidase of beta-N-acetylglucosaminidase, and thus was not associated with membrane or lysosomal enzymes.
D000818:Animals; D000920:Antibody-Dependent Cell Cytotoxicity / Q000187:drug effects; D002462:Cell Membrane / Q000276:immunology; D007111:Immunity, Cellular / Q000187:drug effects; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000648:ultrastructure; D008934:Mitogens / Q000494:pharmacology; D011951:Receptors, Complement / Q000187:drug effects; D011961:Receptors, Fc / Q000187:drug effects; D012397:Rosette Formation; D012756:Sheep; D012867:Skin / Q000032:analysis / Q000276:immunology*; D014020:Tissue Extracts / Q000032:analysis / Q000037:antagonists & inhibitors / Q000494:pharmacology; D014357:Trypsin / Q000008:administration & dosage
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D008934:Mitogens; D011951:Receptors, Complement; D011961:Receptors, Fc; D014020:Tissue Extracts; D014357:Trypsin